Zuventus Healthcare Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 20.06 Cr
- Company Age 22 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 62.00 Cr
- Satisfied Charges ₹ 387.96 Cr
- Revenue Growth 6.46%
- Profit Growth -2.37%
- Ebitda -7.98%
- Net Worth 13.65%
- Total Assets 11.11%
About Zuventus Healthcare
Zuventus Healthcare Limited (ZHL) is a leading Public Limited Indian Non-Government Company incorporated in India on 27 May 2002 and has a history of 22 years and eight months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Zuventus Healthcare P Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 20.06 Cr.
The company currently has active open charges totaling ₹62.00 Cr. The company has closed loans amounting to ₹387.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zuventus Healthcare Limited India are Ganesh Ramachandran as CFO and Ankita Saraogi as Company Secretary. Sanjay Mehta, Prakash Kumar, Satish Mehta, and Five other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85320PN2002PLC018324
- Company No.
018324
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 May 2002
- Date of AGM
05 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Zuventus Healthcare Limited offer?
Zuventus Healthcare Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Sexual Wellness Products, Fertility Enhancer, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Psoriasis Ointment, Diabetes Medicine.
Who are the key members and board of directors at Zuventus Healthcare?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Kumar  | Managing Director | 27-May-2002 | Current |
| Ganesh Ramachandran | CFO | 01-Oct-2021 | Current |
| Ankita Saraogi | Company Secretary | 05-Jun-2024 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Ayyangar  | Director | 26-Jul-2021 | Current |
| Namita Thapar | Director | 03-Jul-2012 | Current |
| Sanjay Mehta | Director | 22-Aug-2006 | Current |
| Satish Mehta | Director | 03-Jul-2002 | Current |
| Shreekant Bapat | Director | 13-Oct-2022 | Current |
| Palamadai Jayakumar | Director | 26-Jul-2022 | Current |
Financial Performance of Zuventus Healthcare.
Zuventus Healthcare Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 6.46% increase. The company also saw a slight decrease in profitability, with a 2.37% decrease in profit. The company's net worth Soared by an impressive increase of 13.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zuventus Healthcare?
In 2024, Zuventus Healthcare had a promoter holding of 79.58% and a public holding of 20.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Noveltech Feeds Private LimitedShailesh Ayyangar is a mutual person
Future Generali India Life Insurance Company LimitedPalamadai Jayakumar is a mutual person
Emcure Pharmaceuticals LimitedSatish Mehta, Shailesh Ayyangar and 3 more are mutual person
Jm Financial LimitedPalamadai Jayakumar is a mutual person
Gennova Biopharmaceuticals LimitedSatish Mehta and Shailesh Ayyangar are mutual person
Universal Nutriscience Private LimitedShailesh Ayyangar is a mutual person
Charges (Loans)
₹62.00 Cr
₹387.96 Cr
Charges Breakdown by Lending Institutions
- Others : 55.00 Cr
- Axis Bank Limited : 7.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2021 | Others | ₹55.00 Cr | Open |
| 12 Jun 2017 | Axis Bank Limited | ₹7.00 Cr | Open |
| 25 Jul 2023 | Others | ₹89.00 Cr | Satisfied |
| 09 Feb 2021 | Others | ₹80.00 Cr | Satisfied |
| 02 Sep 2018 | Hdfc Bank Limited | ₹0.96 M | Satisfied |
How Many Employees Work at Zuventus Healthcare?
Zuventus Healthcare has a workforce of 3438 employees as of Sep 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zuventus Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zuventus Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
